July 26, 2019 / 12:14 PM / 24 days ago

BRIEF-Novartis Receives Positive CHMP Opinion For Lucentis

July 26 (Reuters) - Novartis AG:

* NOVARTIS RECEIVES POSITIVE CHMP OPINION FOR LUCENTIS® TREATMENT IN PRETERM INFANTS WITH RETINOPATHY OF PREMATURITY (ROP), A DISEASE CAUSING VISUAL IMPAIRMENT AND BLINDNESS Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below